Literature DB >> 7509190

Identification of a lipolysis-stimulated receptor that is distinct from the LDL receptor and the LDL receptor-related protein.

F T Yen1, C J Mann, L M Guermani, N F Hannouche, N Hubert, C A Hornick, V N Bordeau, G Agnani, B E Bihain.   

Abstract

This paper provides further characterization of a receptor that, in cells lacking the LDL receptor (FH fibroblasts), mediates lipoprotein binding, uptake, and degradation when incubated with oleate at concentrations not exceeding albumin binding capacity. This oleate-activated receptor is genetically distinct from the LDL receptor and is hereafter referred to as the lipolysis-stimulated receptor (LSR). Its apparent affinity was higher for triglyceride-rich lipoproteins (chylomicrons, VLDL) and for lipid emulsions supplemented with recombinant apoE, than for LDL which contains solely apoB. In contrast, VLDL isolated from a Type III hyperlipidemic patient (apoE2/2 phenotype) failed to bind to the LSR. Five lines of evidence indicated that the LSR is distinct from the LDL receptor-related protein (LRP): (1) the LRP ligand, alpha 2-macroglobulin-methylamine (alpha 2-MG*), did not bind to the oleate-induced LDL binding site; (2) oleate had no effect on the binding of alpha 2-MG* to LRP; (3) the LRP-associated protein, RAP, which inhibits LRP, had no effect on the LSR; (4) binding of lipoproteins to LSR was independent of Ca2+; and (5) LSR activity resolved as two proteins smaller than LRP (apparent molecular masses as determined by ligand blots: 115 and 85 kDa). That LSR provides a new candidate receptor contributing to the clearance of chylomicron remnants (CMR) is supported by the observation that LSR was inhibited by lactoferrin, a milk protein that delays CMR clearance when injected in vivo. Furthermore, in primary cultures of rat hepatocytes, oleate stimulated binding, uptake, and degradation of LDL with kinetic characteristics similar to that of LSR expressed in FH fibroblasts.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7509190     DOI: 10.1021/bi00171a017

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Lipolysis-stimulated lipoprotein receptor (LSR) is the host receptor for the binary toxin Clostridium difficile transferase (CDT).

Authors:  Panagiotis Papatheodorou; Jan E Carette; George W Bell; Carsten Schwan; Gregor Guttenberg; Thijn R Brummelkamp; Klaus Aktories
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  Ligand selectivity of 105 kDa and 130 kDa lipoprotein-binding proteins in vascular-smooth-muscle-cell membranes is unique.

Authors:  V N Bochkov; V A Tkachuk; M P Philippova; D V Stambolsky; F R Bühler; T J Resink
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

3.  Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants.

Authors:  A Rohlmann; M Gotthardt; R E Hammer; J Herz
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

4.  Nuclear Localized LSR: A Novel Regulator of Breast Cancer Behavior and Tumorigenesis.

Authors:  Denise K Reaves; Katherine A Hoadley; Katerina D Fagan-Solis; Dereje D Jima; Michael Bereman; Lynnelle Thorpe; Jyla Hicks; David McDonald; Melissa A Troester; Charles M Perou; Jodie M Fleming
Journal:  Mol Cancer Res       Date:  2016-11-17       Impact factor: 5.852

5.  Interaction of the Clostridium difficile Binary Toxin CDT and Its Host Cell Receptor, Lipolysis-stimulated Lipoprotein Receptor (LSR).

Authors:  Sarah Hemmasi; Bernd A Czulkies; Björn Schorch; Antonia Veit; Klaus Aktories; Panagiotis Papatheodorou
Journal:  J Biol Chem       Date:  2015-04-16       Impact factor: 5.157

6.  Identification of the cellular receptor of Clostridium spiroforme toxin.

Authors:  Panagiotis Papatheodorou; Claudia Wilczek; Thilo Nölke; Gregor Guttenberg; Daniel Hornuss; Carsten Schwan; Klaus Aktories
Journal:  Infect Immun       Date:  2012-01-17       Impact factor: 3.441

7.  Immunoglobulin-like domain containing receptor 1 mediates fat-stimulated cholecystokinin secretion.

Authors:  Rashmi Chandra; Yu Wang; Rafiq A Shahid; Steven R Vigna; Neil J Freedman; Rodger A Liddle
Journal:  J Clin Invest       Date:  2013-07-25       Impact factor: 14.808

8.  Recognition of lactoferrin and aminopeptidase M-modified lactoferrin by the liver: involvement of proteoglycans and the remnant receptor.

Authors:  G J Ziere; J K Kruijt; M K Bijsterbosch; T J van Berkel
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

9.  Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes.

Authors:  Juraj Koska; Hussein Yassine; Olgica Trenchevska; Shripad Sinari; Dawn C Schwenke; Frances T Yen; Dean Billheimer; Randall W Nelson; Dobrin Nedelkov; Peter D Reaven
Journal:  J Lipid Res       Date:  2016-03-03       Impact factor: 5.922

10.  Liver-specific loss of lipolysis-stimulated lipoprotein receptor triggers systemic hyperlipidemia in mice.

Authors:  Prachiti Narvekar; Mauricio Berriel Diaz; Anja Krones-Herzig; Ulrike Hardeland; Daniela Strzoda; Sigrid Stöhr; Marcus Frohme; Stephan Herzig
Journal:  Diabetes       Date:  2009-02-02       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.